Patent · US Active

Ligand-conjugated monomers

US8957223B2 · kind B2 · utility

7Cited by
5References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2012
Grant dateFeb 17, 2015
Priority date—
Expiry dateOct 19, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.